Viewing data from:

FAMCICLOVIR

ANDA

FAMCICLOVIR | A091480 | APOTEX INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.7654

per ea

Lowest NADAC/Unit

$0.4180

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60505324703FAMCICLOVIR 500 MG TABLET	$0.7654	EA	Generic	—	2026-06-17
60505324603FAMCICLOVIR 250 MG TABLET	$0.4180	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs1 inactive

9 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVFAMCICLOVIR

DMF 179082004

CIPLA LTDFAMCICLOVIR USP

DMF 191812006

CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTDFAMCICLOVIR

DMF 196922006

APITORIA PHARMA PRIVATE LTDFAMCICLOVIR USP

DMF 222042008

MACLEODS PHARMACEUTICALS LTDFAMCICLOVIR

DMF 223912009

SIGNA SA DE CVFAMCICLOVIR USP

DMF 227132009

HETERO DRUGS LTDFAMCICLOVIR

DMF 238222010

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDFAMCICLOVIR

DMF 340982019

SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO LTDFAMCICLOVIR

DMF 350502020

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactiveFAMCICLOVIR (NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENT)

DMF 186902005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 125MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 22, 2011

No patent or exclusivity listings for this strength.

#002 — 250MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 22, 2011

#003 — 500MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 22, 2011